ProPhase Labs Inc. Daily Stock Analysis

Daily Stock Analysis, PRPH, ProPhase Labs Inc, priceseries

ProPhase Labs Inc. Daily Stock Analysis
Stock Information
Open
6.50
Close
6.36
High
6.60
Low
6.26
Previous Close
6.55
Daily Price Gain
-0.19
YTD High
7.63
YTD High Date
Jan 4, 2022
YTD Low
6.20
YTD Low Date
Mar 2, 2022
YTD Price Change
-0.71
YTD Gain
-10.08%
52 Week High
7.71
52 Week High Date
Mar 19, 2021
52 Week Low
4.01
52 Week Low Date
Apr 21, 2021
52 Week Price Change
0.53
52 Week Gain
9.08%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 1. 2018
1.12
Mar 21. 2018
1.26
14 Trading Days
12.46%
Link
LONG
May 10. 2018
1.78
May 25. 2018
2.06
11 Trading Days
16.13%
Link
LONG
Jun 5. 2018
2.10
Jun 15. 2018
2.21
8 Trading Days
5.12%
Link
LONG
Nov 26. 2019
1.61
Dec 9. 2019
1.83
8 Trading Days
13.25%
Link
LONG
Jun 17. 2020
1.49
Jun 18. 2020
1.87
1 Trading Days
25.61%
Link
LONG
Jul 29. 2020
1.52
Sep 1. 2020
2.48
24 Trading Days
63.30%
Link
LONG
Sep 10. 2020
2.57
Sep 30. 2020
3.18
14 Trading Days
23.58%
Link
LONG
Oct 1. 2020
3.55
Oct 12. 2020
4.63
7 Trading Days
30.60%
Link
LONG
Oct 15. 2020
4.99
Oct 27. 2020
6.19
8 Trading Days
24.05%
Link
LONG
Oct 30. 2020
6.59
Nov 9. 2020
7.30
6 Trading Days
10.88%
Link
LONG
Nov 24. 2020
7.34
Dec 2. 2020
8.27
5 Trading Days
12.68%
Link
LONG
Jan 4. 2021
9.62
Jan 19. 2021
11.42
10 Trading Days
18.62%
Link
LONG
May 13. 2021
5.06
May 25. 2021
5.49
8 Trading Days
8.49%
Link
LONG
Jul 20. 2021
5.90
Aug 11. 2021
6.81
16 Trading Days
15.47%
Link
Company Information
Stock Symbol
PRPH
Exchange
NasdaqCM
Company URL
http://www.prophaselabs.com
Company Phone
2153450919
CEO
Ted William Karkus
Headquarters
Pennsylvania
Business Address
621 N. SHADY RETREAT ROAD, DOYLESTOWN, PA 18901
Sector
Equity
Industry Category
Drugs
Industry Group
Drug Related Products
CIK
0000868278
About

ProPhase Labs, Inc. engages in the research, development, manufacturing, distribution and marketing of consumer products, natural base health products and other supplements. Its products include Cold-EEZE, Tk supplement ,natural allergy relief, cold and flu relief and Organix Rx Complete. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Doylestown, PA.

Description

ProPhase Labs, Inc. manufactures, markets, and distributes a range of homeopathic and health care products to general public in the United States. The company also engages in the research and development of over-the-counter drugs and natural base health products with supplements, personal care, and cosmeceutical products. It offers Cold-EEZE cold remedy zinc gluconate lozenges that reduces the duration and severity of symptoms of the common cold; and non-lozenge forms of its proprietary zinc gluconate formulation, including Cold-EEZE cold remedy QuickMelts, Cold-EEZE Gummies, and Cold-EEZE cold remedy oral spray. The company's Cold-EEZE cold remedy QuickMelts product line consists of Cold-EEZE Daytime/Nighttime QuickMelts, Cold-EEZE Plus Immune Support + Energy QuickMelts, and Cold-EEZE Plus Multi-Symptom QuickMelts. It also offers Cold-EEZE Multi-Symptom Relief for cold and flu lozenge; Cold-EEZE Daytime and Nighttime Multi-Symptom Relief in liquid form for adults and children; and Cold-EEZE Natural Allergy Relief caplets for indoor and outdoor allergies, as well as Cold-EEZE Nighttime Multi-Symptom Relief for Cold and Flu QuickMelts. In addition, the company provides organic cough drops and a vitamin C supplement; and contract manufacturing services of cough drop, dietary supplements, and other OTC cold remedy products for third parties, as well as produces private label lozenge products for retail customers. It markets its products through national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading